PHARYNGEAL LEUKOPLAKIA

PHARYNGEAL LEUKOPLAKIA was reported 27 times

PHARYNGEAL LEUKOPLAKIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Melanin Synthesis Inhibitor [EPC] 1 0.0009
1 Glucosylceramide Synthase Inhibitor [EPC] 2 0.0007
2 Barbiturate [EPC] 1 0.0001
3 Provitamin D2 Compound [EPC] 1 0.0000
4 Methylxanthine [EPC] 1 0.0000
5 Nitroimidazole Antimicrobial [EPC] 1 0.0000
6 Selective T Cell Costimulation Modulator [EPC] 2 0.0000
7 Tetracycline-class Drug [EPC] 1 0.0000
8 Cardiac Glycoside [EPC] 1 0.0000
9 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
10 Nucleoside Analog Antiviral [EPC] 1 0.0000
11 Anti-IgE [EPC] 1 0.0000
12 Central Nervous System Stimulant [EPC] 1 0.0000
13 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
14 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
15 Aminosalicylate [EPC] 1 0.0000
16 Expectorant [EPC] 2 0.0000
17 Osmotic Laxative [EPC] 2 0.0000
18 Aldosterone Antagonist [EPC] 1 0.0000
19 Azole Antifungal [EPC] 1 0.0000
20 Thiazide Diuretic [EPC] 1 0.0000
21 Vitamin C [EPC] 2 0.0000
22 Loop Diuretic [EPC] 2 0.0000
23 Benzodiazepine [EPC] 3 0.0000
24 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
25 Vitamin D [EPC] 1 0.0000
26 beta-Adrenergic Blocker [EPC] 1 0.0000
27 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
28 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
29 Vitamin B12 [EPC] 1 0.0000
30 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
31 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
32 Proton Pump Inhibitor [EPC] 1 0.0000
33 Corticosteroid [EPC] 2 0.0000